This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prince, G A Articles by Chanock, R M Search for Related Content PubMed PubMed Citation Articles by Prince, G A Articles by Chanock, R M

 Previous Article  |  Next Article 

J Virol. 1986 March; 57(3): 721-728

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus.

ABSTRACT

Cotton rats previously inoculated with Formalin-inactivated respiratory syncytial virus (RSV) were challenged intranasally with live RSV to induce an enhancement of RSV disease similar to that observed after the administration of Formalin-inactivated RSV vaccine to human infants 20 years ago. Within 24 h after infection with RSV, cotton rats developed pulmonary lesions that reached a maximum by day 4. Histologically, the lesions resembled an experimental pulmonary Arthus reaction. An action of Formalin on RSV appears to be responsible for this effect, because live virus or virus heated in the absence of Formalin did not induce enhanced immunopathology. Selected epitopes on the fusion (F) or attachment (G) or both RSV surface glycoproteins that are involved in inducing neutralizing antibodies were modified to reduce or ablate their antigenicity. However, other epitopes on the F or G or both glycoproteins were not ablated by Formalin, because cotton rats inoculated parenterally with a Formalin-inactivated virus developed a high level of F and G antibodies measurable by an enzyme-linked immunosorbent assay. At this time, the effect of Formalin on RSV cannot be localized to either the F or G glycoprotein of RSV.

This article has been cited by other articles:

• Johnson, T. R., Rothenberg, M. E., Graham, B. S. (2008). Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein. J. Leukoc. Biol. 84: 748-759 [Abstract] [Full Text]  
• Mohapatra, S. S., Boyapalle, S. (2008). Epidemiologic, Experimental, and Clinical Links between Respiratory Syncytial Virus Infection and Asthma. Clin. Microbiol. Rev. 21: 495-504 [Abstract] [Full Text]  
• Mok, H., Lee, S., Utley, T. J., Shepherd, B. E., Polosukhin, V. V., Collier, M. L., Davis, N. L., Johnston, R. E., Crowe, J. E. Jr. (2007). Venezuelan Equine Encephalitis Virus Replicon Particles Encoding Respiratory Syncytial Virus Surface Glycoproteins Induce Protective Mucosal Responses in Mice and Cotton Rats. J. Virol. 81: 13710-13722 [Abstract] [Full Text]  
• Boukhvalova, M. S., Prince, G. A., Blanco, J. C. G. (2007). Respiratory Syncytial Virus Infects and Abortively Replicates in the Lungs in Spite of Preexisting Immunity. J. Virol. 81: 9443-9450 [Abstract] [Full Text]  
• Cseke, G., Wright, D. W., Tollefson, S. J., Johnson, J. E., Crowe, J. E. Jr., Williams, J. V. (2007). Human Metapneumovirus Fusion Protein Vaccines That Are Immunogenic and Protective in Cotton Rats. J. Virol. 81: 698-707 [Abstract] [Full Text]  
• Openshaw, P. J. M., Tregoning, J. S. (2005). Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection. Clin. Microbiol. Rev. 18: 541-555 [Abstract] [Full Text]  
• Richardson, J. Y., Ottolini, M. G., Pletneva, L., Boukhvalova, M., Zhang, S., Vogel, S. N., Prince, G. A., Blanco, J. C. G. (2005). Respiratory Syncytial Virus (RSV) Infection Induces Cyclooxygenase 2: A Potential Target for RSV Therapy. J. Immunol. 174: 4356-4364 [Abstract] [Full Text]  
• Johnson, T. R., Varga, S. M., Braciale, T. J., Graham, B. S. (2004). V{beta}14+ T Cells Mediate the Vaccine-Enhanced Disease Induced by Immunization with Respiratory Syncytial Virus (RSV) G Glycoprotein but Not with Formalin-Inactivated RSV. J. Virol. 78: 8753-8760 [Abstract] [Full Text]  
• Johnson, T. R., Teng, M. N., Collins, P. L., Graham, B. S. (2004). Respiratory Syncytial Virus (RSV) G Glycoprotein Is Not Necessary for Vaccine-Enhanced Disease Induced by Immunization with Formalin-Inactivated RSV. J. Virol. 78: 6024-6032 [Abstract] [Full Text]  
• de Swart, R. L., Kuiken, T., Timmerman, H. H., Amerongen, G. v., van den Hoogen, B. G., Vos, H. W., Neijens, H. J., Andeweg, A. C., Osterhaus, A. D. M. E. (2002). Immunization of Macaques with Formalin-Inactivated Respiratory Syncytial Virus (RSV) Induces Interleukin-13-Associated Hypersensitivity to Subsequent RSV Infection. J. Virol. 76: 11561-11569 [Abstract] [Full Text]  
• Polack, F. P., Teng, M. N., L.Collins, P., Prince, G. A., Exner, M., Regele, H., Lirman, D. D., Rabold, R., Hoffman, S. J., Karp, C. L., Kleeberger, S. R., Wills-Karp, M., Karron, R. A. (2002). A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease. J. Exp. Med. 196: 859-865 [Abstract] [Full Text]  
• Power, U. F., Huss, T., Michaud, V., Plotnicky-Gilquin, H., Bonnefoy, J.-Y., Nguyen, T. N. (2001). Differential Histopathology and Chemokine Gene Expression in Lung Tissues following Respiratory Syncytial Virus (RSV) Challenge of Formalin-Inactivated RSV- or BBG2Na-Immunized Mice. J. Virol. 75: 12421-12430 [Abstract] [Full Text]  
• Prince, G. A., Curtis, S. J., Yim, K. C., Porter, D. D. (2001). Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine. J. Gen. Virol. 82: 2881-2888 [Abstract] [Full Text]  
• Ponnuraj, E. M., Hayward, A. R., Raj, A., Wilson, H., Simoes, E. A. F. (2001). Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine. J. Gen. Virol. 82: 2663-2674 [Abstract] [Full Text]  
• Prince, G. A., Capiau, C., Deschamps, M., Fabry, L., Garçon, N., Gheysen, D., Prieels, J.-P., Thiry, G., Van Opstal, O., Porter, D. D. (2000). Efficacy and Safety Studies of a Recombinant Chimeric Respiratory Syncytial Virus FG Glycoprotein Vaccine in Cotton Rats. J. Virol. 74: 10287-10292 [Abstract] [Full Text]  
• Domachowske, J. B., Rosenberg, H. F. (1999). Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment. Clin. Microbiol. Rev. 12: 298-309 [Abstract] [Full Text]  
• Olszewska-Pazdrak, B., Casola, A., Saito, T., Alam, R., Crowe, S. E., Mei, F., Ogra, P. L., Garofalo, R. P. (1998). Cell-Specific Expression of RANTES, MCP-1, and MIP-1alpha by Lower Airway Epithelial Cells and Eosinophils Infected with Respiratory Syncytial Virus. J. Virol. 72: 4756-4764 [Abstract] [Full Text]  
• Johnson, T. R., Johnson, J. E., Roberts, S. R., Wertz, G. W., Parker, R. A., Graham, B. S. (1998). Priming with Secreted Glycoprotein G of Respiratory Syncytial Virus (RSV) Augments Interleukin-5 Production and Tissue Eosinophilia after RSV Challenge. J. Virol. 72: 2871-2880 [Abstract] [Full Text]  
• Groothuis, J. R., Simoes, E., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C., Tristram, D. A., Siber, G. R., Prince, G. A., Van Raden, M., Hemming, V. G., The Respiratory Syncytial Virus Immune Globulin St, (1993). Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children. NEJM 329: 1524-1530 [Abstract] [Full Text]